Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYO1B antisense RNA 1 (MYO1B-AS1) is a long non-coding RNA gene located on human chromosome 2 (chr2:191209191-191246251), transcribed as an antisense RNA overlapping the MYO1B gene region[1]. As an "antisense RNA," it likely participates in gene expression regulation at the RNA level, possibly via mechanisms such as RNA-RNA interactions or chromatin modification, but there are no published functional, biological, or disease association data for this specific lncRNA. Most available literature and disease relationships pertain to the protein-coding MYO1B gene rather than MYO1B-AS1. No evidence supports MYO1B-AS1 as a therapeutic target, biomarker, or disease gene; it should not be confused with the myosin 1B protein-coding gene, which is implicated in cancer and cell migration[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYO1B antisense RNA 1 (MYO1B-AS1).